메뉴 건너뛰기




Volumn 200, Issue 2-3, 2012, Pages 79-82

Rosiglitazone and cognitive function in clozapine-treated patients with schizophrenia: A pilot study

Author keywords

Clozapine; Cognition; Insulin resistance; Rosiglitazone; Schizophrenia

Indexed keywords

PLACEBO; ROSIGLITAZONE;

EID: 84872379601     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2012.05.020     Document Type: Article
Times cited : (18)

References (32)
  • 2
    • 18144442184 scopus 로고    scopus 로고
    • Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia
    • Areosa S.A., Grimley E.J. Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database of Systematic Reviews 4 2002, CD003408.
    • (2002) Cochrane Database of Systematic Reviews 4
    • Areosa, S.A.1    Grimley, E.J.2
  • 3
    • 9644291424 scopus 로고    scopus 로고
    • The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function
    • Awad N., Gagnon M., Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology 2004, 26:1044-1080.
    • (2004) Journal of Clinical and Experimental Neuropsychology , vol.26 , pp. 1044-1080
    • Awad, N.1    Gagnon, M.2    Messier, C.3
  • 5
    • 0032572613 scopus 로고    scopus 로고
    • Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment
    • Biessels G.J., Kamal A., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Research 1998, 27:125-135.
    • (1998) Brain Research , vol.27 , pp. 125-135
    • Biessels, G.J.1    Kamal, A.2    Urban, I.J.3    Spruijt, B.M.4    Erkelens, D.W.5    Gispen, W.H.6
  • 6
    • 1842684436 scopus 로고    scopus 로고
    • Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface
    • Biessels G.J., Bravenboer B., Gispen W.H. Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface. European Journal of Pharmacology 2004, 490:1-4.
    • (2004) European Journal of Pharmacology , vol.490 , pp. 1-4
    • Biessels, G.J.1    Bravenboer, B.2    Gispen, W.H.3
  • 8
    • 0034651101 scopus 로고    scopus 로고
    • Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists
    • Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. Journal of Neuroscience 2000, 20:558-567.
    • (2000) Journal of Neuroscience , vol.20 , pp. 558-567
    • Combs, C.K.1    Johnson, D.E.2    Karlo, J.C.3    Cannady, S.B.4    Landreth, G.E.5
  • 9
    • 1242316296 scopus 로고    scopus 로고
    • Insulin and neurodegenerative disease: shared and specific mechanisms
    • Craft S., Watson G.S. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurology 2004, 3:169-178.
    • (2004) Lancet Neurology , vol.3 , pp. 169-178
    • Craft, S.1    Watson, G.S.2
  • 10
    • 65349113335 scopus 로고    scopus 로고
    • Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem
    • Dickinson D., Harvey P.D. Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. Schizophrenia Bulletin 2009, 35:403-414.
    • (2009) Schizophrenia Bulletin , vol.35 , pp. 403-414
    • Dickinson, D.1    Harvey, P.D.2
  • 12
    • 0029918481 scopus 로고    scopus 로고
    • What are the functional consequences of neurocognitive deficits in schizophrenia?
    • Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. American Journal of Psychiatry 1996, 153:321-330.
    • (1996) American Journal of Psychiatry , vol.153 , pp. 321-330
    • Green, M.F.1
  • 13
    • 0003968285 scopus 로고
    • Psychological Assessment Resources, Odessa, FL
    • Heaton R.K. Wisconsin Card Sort Manual 1981, Psychological Assessment Resources, Odessa, FL.
    • (1981) Wisconsin Card Sort Manual
    • Heaton, R.K.1
  • 16
    • 34247470659 scopus 로고    scopus 로고
    • Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics
    • Henderson D.C., Cagliero E., Copeland P.M., Louie P.M., Borba C.P., Fan X., Freudenreich O., Goff D.C. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. Journal of Clinical Psychiatry 2007, 68:533-541.
    • (2007) Journal of Clinical Psychiatry , vol.68 , pp. 533-541
    • Henderson, D.C.1    Cagliero, E.2    Copeland, P.M.3    Louie, P.M.4    Borba, C.P.5    Fan, X.6    Freudenreich, O.7    Goff, D.C.8
  • 22
    • 0032977410 scopus 로고    scopus 로고
    • The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
    • Meltzer H.Y., McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin 1999, 25:233-255.
    • (1999) Schizophrenia Bulletin , vol.25 , pp. 233-255
    • Meltzer, H.Y.1    McGurk, S.R.2
  • 23
    • 70450247208 scopus 로고    scopus 로고
    • Management of schizophrenia with obesity, metabolic, and endocrinological disorders
    • Monteleone P., Martiadis V., Maj M. Management of schizophrenia with obesity, metabolic, and endocrinological disorders. Psychiatric Clinics of North America 2009, 32:775-794.
    • (2009) Psychiatric Clinics of North America , vol.32 , pp. 775-794
    • Monteleone, P.1    Martiadis, V.2    Maj, M.3
  • 24
    • 0030972350 scopus 로고    scopus 로고
    • Cognitive function in schizophrenia-do neuroleptics make a difference?
    • Mortimer A. Cognitive function in schizophrenia-do neuroleptics make a difference?. Pharmacology, Biochemistry, and Behavior 1997, 56:789-795.
    • (1997) Pharmacology, Biochemistry, and Behavior , vol.56 , pp. 789-795
    • Mortimer, A.1
  • 26
    • 0242609178 scopus 로고    scopus 로고
    • Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase
    • Sastre M., Dewachter I., Landreth G.E., Willson T.M., Klockgether T., van Leuven F., Heneka MT. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. Journal of Neuroscience 2003, 23:9796-9804.
    • (2003) Journal of Neuroscience , vol.23 , pp. 9796-9804
    • Sastre, M.1    Dewachter, I.2    Landreth, G.E.3    Willson, T.M.4    Klockgether, T.5    van Leuven, F.6    Heneka, M.T.7
  • 28
    • 0026769858 scopus 로고
    • The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale, and description
    • Spitzer R.L., Williams J.B., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale, and description. Archives of General Psychiatry 1992, 49:624-629.
    • (1992) Archives of General Psychiatry , vol.49 , pp. 624-629
    • Spitzer, R.L.1    Williams, J.B.2    Gibbon, M.3    First, M.B.4
  • 29
    • 0037221379 scopus 로고    scopus 로고
    • The role of insulin-resistance in the pathogenesis of Alzheimer's disease: implication for treatment
    • Watson G.S., Craft S. The role of insulin-resistance in the pathogenesis of Alzheimer's disease: implication for treatment. CNS Drugs 2003, 17:27-45.
    • (2003) CNS Drugs , vol.17 , pp. 27-45
    • Watson, G.S.1    Craft, S.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.